Research into Dravet syndrome spans multiple therapeutic approaches and trial phases.

13 total trials for this combination

Showing top 10 of 13 trials

Trials

NCT ID	Title	Status	Phase
NCT06660394	A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)	RECRUITING	—
NCT03936777	A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome	COMPLETED	PHASE3
NCT04537832	Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies	TERMINATED	—
NCT02091375	Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)	COMPLETED	PHASE3
NCT02826863	A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome	UNKNOWN_STATUS	PHASE3
NCT02926898	A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome	COMPLETED	PHASE3
NCT06872125	A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome	RECRUITING	PHASE3
NCT02682927	A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome	COMPLETED	PHASE3
NCT02823145	An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome	COMPLETED	PHASE3
NCT06504511	SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom	RECRUITING	—

Related Pages

All Dravet syndrome trials All trials in Glasgow, United Kingdom